Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Nov;119(10):1191-1199.
doi: 10.1038/s41416-018-0210-y. Epub 2018 Oct 24.

Irradiance controls photodynamic efficacy and tissue heating in experimental tumours: implication for interstitial PDT of locally advanced cancer

Gal Shafirstein  1   2 , David A Bellnier  3   4 , Emily Oakley  3   4 , Sasheen Hamilton  3   4 , Michael Habitzruther  3   4 , Lawrence Tworek  3   4 , Alan Hutson  5 , Joseph A Spernyak  4   6 , Sandra Sexton  7 , Leslie Curtin  7 , Steven G Turowski  6 , Hassan Arshad  8 , Barbara Henderson  3   4
Affiliations

Irradiance controls photodynamic efficacy and tissue heating in experimental tumours: implication for interstitial PDT of locally advanced cancer

Gal Shafirstein et al. Br J Cancer. 2018 Nov.

Abstract

Background: Currently delivered light dose (J/cm2) is the principal parameter guiding interstitial photodynamic therapy (I-PDT) of refractory locally advanced cancer. The aim of this study was to investigate the impact of light dose rate (irradiance, mW/cm2) and associated heating on tumour response and cure.

Methods: Finite-element modeling was used to compute intratumoural irradiance and dose to guide Photofrin® I-PDT in locally advanced SCCVII in C3H mice and large VX2 neck tumours in New Zealand White rabbits. Light-induced tissue heating in mice was studied with real-time magnetic resonance thermometry.

Results: In the mouse model, cure rates of 70-90% were obtained with I-PDT using 8.4-245 mW/cm2 and ≥45 J/cm2 in 100% of the SCCVII tumour. Increasing irradiance was associated with increase in tissue heating. I-PDT with Photofrin® resulted in significantly (p < 0.05) higher cure rate compared to light delivery alone at same irradiance and light dose. Local control and/or cures of VX2 were obtained using I-PDT with 16.5-398 mW/cm2 and ≥45 J/cm2 in 100% of the tumour.

Conclusion: In Photofrin®-mediated I-PDT, a selected range of irradiance prompts effective photoreaction with tissue heating in the treatment of locally advanced mouse tumour. These irradiances were translated for effective local control of large VX2 tumours.

PubMed Disclaimer

Conflict of interest statement

G.S., D.A.B., and E.O. are co-inventors in patent applications (owned by Roswell Park Comprehensive Cancer Center) of a light dosimetry system for interstitial and thermal photodynamic therapy. G.S. and H.A. acknowledge research grant support from Concordia Laboratories, Inc. G.S. acknowledges a service on the advisory board for Concordia International Corp. and Pinnacle Biologics, Inc. The remaining authors declare no competing interests. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or Roswell Park Comprehensive Cancer Center.

Figures

Fig. 1
Fig. 1
Pseudo-colourised temperature maps (°C) within the tumour as measured by MR thermometry at the end of the laser irradiation for different light intensities. A light energy of 100 J/cm was delivered through a single 2-cm cylindrical-diffuser fiber. There was no difference in the temperature field in mice treated with or without Photofrin. Hence, the images are shown as function of light intensity only (a–e): 60, 100, 150, 200, and 400 mW/cm. Yellow arrows denote location of treatment fibers. A nuclear magnetic resonance tube filled with cottonseed oil was used as a phase normalisation reference (white arrows). Noteworthy, the non-concentric isotherms, around the cylindrical-diffuser fibers, suggest that the fibers itself was not heated. The increase in temperature was attributed to light absorption by blood, as detailed in the discussion
Fig. 2
Fig. 2
The distributions of percentage of tumour volume >60 °C were summarised using boxplots across the mW/cm settings. a Single fiber with 2-cm cylindrical diffuser at 100 J/cm. b Two fibers with 2-cm cylindrical diffusers at 540 J/cm. The top, middle, and bottom lines of a box in the boxplots indicate the 25th percentile, median, and 75th percentile, respectively. The “whiskers” in the boxplots represent the range of the data. Open circles in the plot show the values that are beyond 1.5 box lengths from the end of the box
Fig. 3
Fig. 3
a The percent tumour volume that will be illuminated at 14–75 mW/cm2 vs. light intensity delivered through two 2-cm cylindrical diffusers at 6.31 ± 0.11 mm apart. b The representative geometry (used in a) constructed from magnetic resonance imaging of a tumour (556 mm3) with two fibers, and the mesh generated in the finite-element modeling. c The three-dimensional distribution of the light irradiance for an input light intensity of 60 mW/cm per fiber. The minimum and maximum irradiances were 5.0 and 147 mW/cm², respectively. d Pseudo-colourised temperature maps (°C) within the tumour as measured by MR thermometry at the end of the laser irradiation for different light intensities. A light energy of 540 J/cm was delivered through two 2-cm cylindrical-diffuser fibers at 6 ± 1 mm apart. Yellow arrows denote location of treatment fibers. A nuclear magnetic resonance tube filled with cottonseed oil was used as a phase normalisation reference (white arrows)
Fig. 4
Fig. 4
The cure rate (C), tumour progression (P), and death (D) of mice with locally advanced SCCVII treated with interstitial light (630 ± 3 nm; 540 J/cm) delivered through two-optical fibers with a 2-cm cylindrical light diffuser end, placed 6 ± 1 mm apart. a Mice treated with light-only or I-PDT with 5 mg/kg Photofrin®. b Kaplan–Meier plots comparing LITH with I-PDT at 100 mW/cm, 540 J/cm with 3.3, 5.0, and 6.6 mg/kg Photofrin®. The I-PDT with 6.6 mg/kg result in a 90% cure that was significantly better (p = 0.025) than light-only
Fig. 5
Fig. 5
a Image of the rabbit treated with I-PDT. Visible in the image are the transparent close-end sharp catheters where treatment or dosimetry fibers were inserted. The blue probes are the optical thermometers that were placed on the tumour surface at margins. b 3D representation of the treatment plan. The tumour is represented in blue. The intended treatment fibers are in green and the intended location of dosimetry fibers are in red. c 3D representation of the intratumoural irradiance throughout the tumour. d CT scan prior to treatment, and (e) a CT scan, 13 weeks post treatment, showing no evidence of cancer
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Zafereo ME, et al. The role of salvage surgery in patients with recurrent squamous cell carcinoma of the oropharynx. Cancer. 2009;115:5723–5733. doi: 10.1002/cncr.24595. - DOI - PubMed
    1. Vermorken JB, et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer. N. Engl. J. Med. 2008;359:1116–1127. doi: 10.1056/NEJMoa0802656. - DOI - PubMed
    1. Mendenhall WM, Mendenhall CM, Malyapa RS, Palta JR, Mendenhall NP. Re-irradiation of head and neck carcinoma. Am. J. Clin. Oncol. 2008;31:393–398. doi: 10.1097/COC.0b013e3181637398. - DOI - PubMed
    1. Wong SJ, Spencer S. Reirradiation and concurrent chemotherapy after salvage surgery: pay now or pay later. J. Clin. Oncol. 2008;26:5500–5501. doi: 10.1200/JCO.2008.19.0868. - DOI - PubMed
    1. McDonald MW, et al. ACR appropriateness criteria retreatment of recurrent head and neck cancer after prior definitive radiation expert panel on radiation oncology-head and neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 2011;80:1292–1298. doi: 10.1016/j.ijrobp.2011.02.014. - DOI - PubMed

Publication types

Substances